Troels Peter Troelsen

Directeur/Membre du Conseil chez ABACUS MEDICINE A/S

Fortune : 770 706 $ au 30/04/2024

78 ans

22 relations

Health Technology

Finance

Distribution Services

Relations actives

Nom	Sexe	Age	Sociétés liées	Collaboration
Flemming Wagner	M	-	ABACUS MEDICINE A/S	20 ans
Soren Nielsen	M	-	Reponex Pharmaceuticals A/S Reponex Pharmaceuticals A/S BiotechnologyHealth Technology Part of Pharma Equity Group A/S, Reponex Pharmaceuticals A/S operates as a Danish clinical stage biopharmaceutical company. The company is based in Hørsholm, Denmark. The company was founded in 2006. The CEO is Soren Nielsen. Reponex Pharmaceuticals was acquired by Pharma Equity Group A/S on March 24, 2023 for $109.83 million. AKI Therapeutics ApS AKI Therapeutics ApS Pharmaceuticals: MajorHealth Technology AKI Therapeutics ApS is a Danish pharmaceutical company that manufactures pharmaceutical products. The private company is based in Hørsholm, Denmark and was founded in 2016.	-
Christian Vinding Thomsen	M	-	AKI Therapeutics ApS AKI Therapeutics ApS Pharmaceuticals: MajorHealth Technology AKI Therapeutics ApS is a Danish pharmaceutical company that manufactures pharmaceutical products. The private company is based in Hørsholm, Denmark and was founded in 2016. Reponex Pharmaceuticals A/S Reponex Pharmaceuticals A/S BiotechnologyHealth Technology Part of Pharma Equity Group A/S, Reponex Pharmaceuticals A/S operates as a Danish clinical stage biopharmaceutical company. The company is based in Hørsholm, Denmark. The company was founded in 2006. The CEO is Soren Nielsen. Reponex Pharmaceuticals was acquired by Pharma Equity Group A/S on March 24, 2023 for $109.83 million.	3 ans
Peter Morch Eriksen	M	64	Reponex Pharmaceuticals A/S Reponex Pharmaceuticals A/S BiotechnologyHealth Technology Part of Pharma Equity Group A/S, Reponex Pharmaceuticals A/S operates as a Danish clinical stage biopharmaceutical company. The company is based in Hørsholm, Denmark. The company was founded in 2006. The CEO is Soren Nielsen. Reponex Pharmaceuticals was acquired by Pharma Equity Group A/S on March 24, 2023 for $109.83 million.	-
Michael Vilhelmsen	M	-	ABACUS MEDICINE A/S	6 ans
Mogens Hobolth	M	-	ABACUS MEDICINE A/S	-
Troels Ring	M	-	AKI Therapeutics ApS AKI Therapeutics ApS Pharmaceuticals: MajorHealth Technology AKI Therapeutics ApS is a Danish pharmaceutical company that manufactures pharmaceutical products. The private company is based in Hørsholm, Denmark and was founded in 2016.	-
Mark Johnston	M	-	ABACUS MEDICINE A/S	5 ans
Lene Bech McCormick	F	-	ABACUS MEDICINE A/S	9 ans
Ole Lindhardt	M	-	ABACUS MEDICINE A/S	7 ans
Nick Nyborg	M	-	ABACUS MEDICINE A/S	-
Kasper Yde	M	-	ABACUS MEDICINE A/S	-
Anders Kunze Bønding	M	59	ABACUS MEDICINE A/S	5 ans
Frederik Heupel	M	-	ABACUS MEDICINE A/S	-
Michala Fischer-Hansen	F	-	ABACUS MEDICINE A/S	3 ans
Lars V. Jenster	M	-	ABACUS MEDICINE A/S	-
Jens Albert Harsaae	M	-	ABACUS MEDICINE A/S	5 ans
Niels Smedegaard	M	61	ABACUS MEDICINE A/S	4 ans
Lars Otto Uttenthal	M	79	AKI Therapeutics ApS AKI Therapeutics ApS Pharmaceuticals: MajorHealth Technology AKI Therapeutics ApS is a Danish pharmaceutical company that manufactures pharmaceutical products. The private company is based in Hørsholm, Denmark and was founded in 2016.	-
Charlotte Pahl	F	-	Reponex Pharmaceuticals A/S Reponex Pharmaceuticals A/S BiotechnologyHealth Technology Part of Pharma Equity Group A/S, Reponex Pharmaceuticals A/S operates as a Danish clinical stage biopharmaceutical company. The company is based in Hørsholm, Denmark. The company was founded in 2006. The CEO is Soren Nielsen. Reponex Pharmaceuticals was acquired by Pharma Equity Group A/S on March 24, 2023 for $109.83 million.	-

Graphique Relationnel

Relation dans plusieurs entreprises

Anciennes relations

Nom	Sexe	Age	Sociétés liées	Collaboration
Henrik Knudsen	M	-	ABACUS MEDICINE A/S	-
Ole Jensen	M	-	ABACUS MEDICINE A/S	-

Statistiques

Pays	Relations	% du total
Danemark	22	100,00%

Age des relations

Actives

Passées

Homme

Femme

Administrateurs

Exécutifs

Provenance des relations